An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: results from the Losartan Intervention For Endpoint reduction (LIFE) study adapted to The Netherlands.
Clin Ther
; 29(5): 963-971, 2007 May.
Article
en En
| MEDLINE
| ID: mdl-17697915
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Atenolol
/
Hipertrofia Ventricular Izquierda
/
Losartán
/
Hipertensión
/
Antihipertensivos
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Health_economic_evaluation
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
Europa
Idioma:
En
Revista:
Clin Ther
Año:
2007
Tipo del documento:
Article